Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis

OBJECTIVE: Transcatheter arterial chemoembolization (TACE) and thalidomide have been used for treating primary hepatocellular carcinoma(HCC). This study aims to evaluate the clinical efficacy and safety of thalidomide and TACE in primary HCC. METHODS: Randomized controlled trials(RCTs) about efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, De-Dong, Xu, Hui-Lin, Liu, Liang, Zheng, Yong-Fa, Gao, Si-Fa, Xu, Xi-Ming, Ge, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546534/
https://www.ncbi.nlm.nih.gov/pubmed/28402958
http://dx.doi.org/10.18632/oncotarget.16689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546534/
https://www.ncbi.nlm.nih.gov/pubmed/28402958
http://dx.doi.org/10.18632/oncotarget.16689

Ejemplares similares